The largest community of pharma leaders

RAPT Therapeutics Announces Promotion of Key Research and Development Senior Leaders

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company developing oral small molecules for oncology and inflammatory diseases, today announced the promotion of Dirk Brockstedt, Ph.D., to chief scientific officer and David Wustrow, Ph.D., to senior vice president, drug discovery and preclinical development. “The leadership and vision that Dirk and Dave have brought to advance the research at RAPT and translate these….



Recent Articles